{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:53:31Z","timestamp":1791172411119,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,7]]},"DOI":"10.1212\/wnl.47.1.219","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T09:21:25Z","timestamp":1336900885000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":75,"title":["Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum"],"prefix":"10.1212","volume":"47","author":[{"given":"M.-T.","family":"Herrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ruberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Luquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Villares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Faucheux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Javoy-Agid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Agid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Obeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"1","volume":"60","year":"1993","unstructured":"Yahr MD. Parkinson's disease: the L-dopa era. In: Parkinson's disease from basic research to treatment. Adv Neurol 1993;60:11-17.","journal-title":"Adv Neurol"},{"key":"e_1_3_1_3_2","first-page":"5","volume":"60","year":"1993","unstructured":"Wichmann T, DeLong MR. Pathophysiology of parkinsonian motor abnormalities. In: Parkinson's disease from basic research to treatment. Adv Neurol 1993;60:53-61.","journal-title":"Adv Neurol"},{"key":"e_1_3_1_4_2","first-page":"4","volume":"56","year":"1993","unstructured":"Herrero MT, Hirsch EC, Kastner A, et al. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 1993;56:499-511.","journal-title":"Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience"},{"key":"e_1_3_1_5_2","first-page":"2","volume":"89","year":"1992","unstructured":"Bu DF, Erlander MG, Hitz BC, et al. Two human glutamate decarboxylase, 65-kDa GAD and 67-kDa GAD, are encoded by a single gene. Proc Natl Acad Sci USA 1992;89:2115-2119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1988.tb02890.x"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902620102"},{"key":"e_1_3_1_8_2","first-page":"5","volume":"157","year":"1993","unstructured":"Herrero MT, Ruberg M, Hirsch EC, et al. In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels. Neurosci Lett 1993;157:57-61.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_9_2","first-page":"2","volume":"162","year":"1968","unstructured":"Bisconte JC, Fulcrand J, Marty R. Analyse radioautographique dans le systeme nerveux central par photometrie et cartographie combinees. CR Soc Biol 1968;162:2178.","journal-title":"CR Soc Biol"},{"key":"e_1_3_1_10_2","first-page":"2","volume":"38","year":"1990","unstructured":"Javoy-Agid F, Hirsch EC, Dumas S, et al. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study. Neuroscience 1990;38:245-253.","journal-title":"Neuroscience"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.1.1"},{"key":"e_1_3_1_12_2","first-page":"9","volume":"234","year":"1959","unstructured":"Albers RW, Brady RO. The distribution of glutamic decarboxylase in the nervous system of the rhesus monkey. J Biol Chem 1959;234:926-928.","journal-title":"J Biol Chem"},{"key":"e_1_3_1_13_2","first-page":"3","volume":"1","year":"1970","unstructured":"Chalmers A, McGeer EG, Wickson V. McGeer PL. Distribution of glutamic acid decarboxylase in the brains of various mammalian species. Comp Gen Pharmacol 1970;1:385-390.","journal-title":"Comp Gen Pharmacol"},{"key":"e_1_3_1_14_2","first-page":"6","volume":"26","year":"1976","unstructured":"McGeer PL, McGeer EG. Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson's disease and Huntington's chorea. J Neurochem 1976;26:65-76.","journal-title":"J Neurochem"},{"key":"e_1_3_1_15_2","first-page":"8","volume":"30","year":"1978","unstructured":"Mackay AVP, Davis P, Dawar AJ, Yates CM. Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain. J Neurochem 1978;30:827-839.","journal-title":"J Neurochem"},{"key":"e_1_3_1_16_2","first-page":"3","volume":"108","year":"1985","unstructured":"Monfort JC, Javoy-Agid F, Hauw JJ, et al. Brain glutamate decarboxylase in Parkinson's disease with particular reference to premortem severity index. Brain 1985;108:301-313.","journal-title":"Brain"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490160103"},{"key":"e_1_3_1_18_2","first-page":"2","volume":"119","year":"1993","unstructured":"Salin P, Chesselet MF. Expression of GAD (M sub r 67,000) and its messenger RNA in basal ganglia and cerebral cortex after ischemic cortical lesions in rats. Exp Neurol 1993;119:291-301.","journal-title":"Exp Neurol"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000114598"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1995.tb01014.x"},{"key":"e_1_3_1_21_2","first-page":"3","volume":"60","year":"1993","unstructured":"Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993;60:395-407.","journal-title":"J Neurochem"},{"key":"e_1_3_1_22_2","first-page":"3","volume":"39","year":"1981","unstructured":"Gale K, Casu M. Dynamic utilization of GABA in the substantia nigra: regulation by dopamine and GABA in the striatum and its clinical and behavioural implications. Mol Cell Biochem 1981;39:369-405.","journal-title":"Mol Cell Biochem"},{"key":"e_1_3_1_23_2","first-page":"4","volume":"14","year":"1988","unstructured":"Bara H, Lassman H, Hornykiewicz O. Behavioural and neurochemical changes 6 months after kainic acid. Soc Neurosci Abstr 1988;14:472.","journal-title":"Soc Neurosci Abstr"},{"key":"e_1_3_1_24_2","first-page":"3","volume":"26","year":"1988","unstructured":"Marksteiner J, Sperk G. Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in frontal cortex of rats with decreased seizure threshold. Neuroscience 1988;26:379-385.","journal-title":"Neuroscience"},{"key":"e_1_3_1_25_2","first-page":"2","volume":"7","year":"1990","unstructured":"Linderfors N, Brene S, Persson H. Increased expression of glutamic acid decarboxylase in rat substantia nigra after ibotenic acid lesion in the caudate-putamen. Mol Brain Res 1990;7:207-212.","journal-title":"Mol Brain Res"},{"key":"e_1_3_1_26_2","first-page":"9","volume":"531","year":"1990","unstructured":"Robertson RG, Clarke CA, Boyce S, et al. The role of striatopallidal neurons utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [sup 3 H]flunitrazepam autoradiography. Brain Res 1990;531:95-104.","journal-title":"Brain Res"},{"key":"e_1_3_1_27_2","first-page":"2","volume":"13","year":"1990","unstructured":"Alexander GE, Crutcher MD. Functional architecture of the basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-271.","journal-title":"Trends Neurosci"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.250.4980.1"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)90567-F"},{"key":"e_1_3_1_30_2","first-page":"4","volume":"8","year":"1993","unstructured":"Guridi J, Luquin MR, Herrero MT, Obeso JA. The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease. Mov Disord 1993;8:421-429.","journal-title":"Mov Disord"},{"key":"e_1_3_1_31_2","first-page":"1","volume":"19","year":"1993","unstructured":"Guridi J, Herrero MT, Ruberg M, et al. Decreased GAD mRNA expression in internal pallidum and substantia nigra pars reticulata after subthalamotomy in MPTP-treated monkeys. Soc Neurosci Abstr 1993;19:133.","journal-title":"Soc Neurosci Abstr"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870090103"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90450-T"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.1.219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T06:27:10Z","timestamp":1711520830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.1.219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,7]]}},"alternative-id":["10.1212\/WNL.47.1.219"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.1.219","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,7]]}}}